Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.1 trillion and total revenue of $110.18 billion.
Market Cap
1.1T
Revenue
110.18B
Profits
-39.66B
PE Ratio
n/a
Profit Margin
-36.00%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.51B | -1.77% | 246,222 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.95B | -1.73% | 139,739 | 14.34B |
| 3 | ARGX | argenx SE | 46.37B | 0.30% | 162,095 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.78B | -4.64% | 402,229 | 3.71B |
| 5 | INSM | Insmed Incorporated | 34.54B | -2.32% | 274,904 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 33.35B | -0.59% | 50,871 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 26.90B | -1.47% | 660,484 | 2.38B |
| 8 | BNTX | BioNTech SE | 22.23B | -3.71% | 259,810 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.68B | -1.36% | 889,779 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 19.15B | -1.00% | 1,170,167 | 1.94B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.72B | -0.96% | 314,652 | - |
| 12 | INCY | Incyte Corporation | 18.64B | -1.27% | 373,236 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.77B | -2.67% | 913,877 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.51B | 0.11% | 351,805 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.74B | -1.91% | 475,526 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.50B | -2.95% | 182,203 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.01B | -2.17% | 433,487 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.61B | -5.20% | 137,878 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.61B | 0.89% | 223,326 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.47B | 0.43% | 762,045 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.74B | -0.66% | 328,872 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.27B | -3.21% | 245,794 | 5.37M |
| 23 | PCVX | Vaxcyte, Inc. | 8.59B | -0.25% | 386,195 | - |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.48B | -2.29% | 97,697 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.45B | -2.18% | 89,197 | 7.46M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.38B | -2.11% | 334,505 | 1.09B |
| 27 | TECH | Bio-Techne Corporation | 8.32B | -1.21% | 1,090,075 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.00B | -1.85% | 144,756 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 7.97B | -0.32% | 334,848 | 88.04M |
| 30 | KRYS | Krystal Biotech, Inc. | 7.67B | -0.51% | 72,729 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.52B | 0.62% | 315,599 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 6.99B | -4.38% | 6,455,991 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.77B | -2.71% | 68,085 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.74B | 0.07% | 452,375 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.63B | -1.53% | 33,412 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.48B | -1.33% | 117,422 | 46.02M |
| 37 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.50% | 853,605 | 15.00M |
| 38 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.28% | 19,923,979 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.06B | -2.39% | 95,420 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | -2.67% | 219,380 | 189.76M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.75B | -0.93% | 125,293 | 521.31M |
| 42 | CGON | CG Oncology, Inc. | 5.73B | 0.50% | 413,639 | 4.04M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.68B | -0.32% | 166,591 | 1.73B |
| 44 | COGT | Cogent Biosciences, Inc. | 5.58B | -2.12% | 407,773 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.55B | -1.07% | 175,252 | - |
| 46 | CELC | Celcuity Inc. | 5.51B | -0.25% | 273,463 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | -0.28% | 114,488 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.21B | -3.05% | 452,409 | 812.03M |
| 49 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.12% | 1,862,629 | 1.00B |
| 50 | ERAS | Erasca, Inc. | 5.03B | -5.55% | 1,168,368 | - |
| 51 | TGTX | TG Therapeutics, Inc. | 4.92B | -1.07% | 327,432 | 616.29M |
| 52 | IMVT | Immunovant, Inc. | 4.88B | -3.74% | 298,172 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 4.63B | -1.77% | 385,437 | 3.51M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.03% | 579,741 | 634.21M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | -1.68% | 92,517 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.33B | -0.32% | 256,059 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.00B | -1.54% | 63,904 | 268.09M |
| 58 | SYRE | Spyre Therapeutics, Inc. | 3.89B | 1.02% | 182,796 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | -1.56% | 869,616 | 7.70M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.80B | -3.02% | 398,726 | 22.50M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.80B | -3.33% | 614,536 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -1.66% | 340,830 | 1.07B |
| 63 | GPCR | Structure Therapeutics Inc. | 3.65B | -0.52% | 304,227 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.43B | -2.71% | 209,761 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.29B | -4.76% | 523,190 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.18B | 4.84% | 124,508 | 803.79M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | -0.06% | 499,156 | 588.99M |
| 68 | DNLI | Denali Therapeutics Inc. | 2.99B | -2.73% | 462,063 | - |
| 69 | TVTX | Travere Therapeutics, Inc. | 2.95B | 0.50% | 565,006 | 490.73M |
| 70 | DYN | Dyne Therapeutics, Inc. | 2.95B | -2.67% | 260,032 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.92B | -2.15% | 61,902 | 451.36M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 2.89B | -1.50% | 146,503 | 376.07M |
| 73 | ORKA | Oruka Therapeutics, Inc. | 2.84B | 1.86% | 412,301 | - |
| 74 | VERA | Vera Therapeutics, Inc. | 2.81B | -2.56% | 306,735 | - |
| 75 | TNGX | Tango Therapeutics, Inc. | 2.75B | -5.03% | 434,334 | 62.38M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.73B | -3.99% | 341,772 | 218.71M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.72B | -2.34% | 167,602 | 247.00M |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.70B | 0.02% | 8,863,906 | 190.41M |
| 79 | ALMS | Alumis Inc. | 2.69B | -3.69% | 384,612 | 24.05M |
| 80 | KOD | Kodiak Sciences Inc. | 2.49B | 3.51% | 331,308 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.48B | -1.11% | 93,722 | - |
| 82 | ELVN | Enliven Therapeutics, Inc. | 2.45B | 5.29% | 1,198,738 | - |
| 83 | AAPG | Ascentage Pharma Group International | 2.44B | 0.36% | 1,036 | 82.08M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.40B | -0.48% | 208,064 | 1.55M |
| 85 | IMNM | Immunome, Inc. | 2.37B | -2.56% | 314,677 | 6.94M |
| 86 | BEAM | Beam Therapeutics Inc. | 2.35B | -2.23% | 477,753 | 139.74M |
| 87 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | -2.54% | 511,583 | 2.20B |
| 88 | ZLAB | Zai Lab Limited | 2.31B | -0.10% | 110,661 | 460.16M |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.31B | 3.61% | 1,636,179 | 15.36M |
| 90 | MANE | Veradermics, Incorporated | 2.29B | -3.96% | 69,836 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -1.66% | 491,003 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.22B | -1.14% | 406,490 | 673.00M |
| 93 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.09% | 507,537 | 158.18M |
| 94 | ADMA | ADMA Biologics, Inc. | 2.21B | 0.11% | 909,153 | 510.17M |
| 95 | NKTR | Nektar Therapeutics | 2.15B | 0.19% | 178,708 | 55.23M |
| 96 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | -0.16% | 308,667 | 172.35M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.62% | 355,920 | 283.06M |
| 98 | ADPT | Adaptive Biotechnologies Corporation | 2.06B | -4.83% | 363,612 | 276.98M |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | -0.24% | 177,759 | 54.03M |
| 100 | TYRA | Tyra Biosciences, Inc. | 2.00B | -4.62% | 287,897 | - |
| 101 | DFTX | Definium Therapeutics, Inc. | 2.00B | -1.86% | 412,459 | - |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.96B | 0.95% | 155,307 | 184.42M |
| 103 | GLPG | Galapagos NV | 1.95B | -3.45% | 161,892 | 1.31B |
| 104 | ZYME | Zymeworks Inc. | 1.87B | -1.82% | 128,420 | 105.97M |
| 105 | PHVS | Pharvaris N.V. | 1.80B | -2.86% | 69,362 | - |
| 106 | MESO | Mesoblast Limited | 1.77B | -9.48% | 232,329 | 65.38M |
| 107 | ANAB | AnaptysBio, Inc. | 1.76B | -1.85% | 66,348 | 234.60M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.75B | -3.76% | 219,977 | 11.13M |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.75B | -0.37% | 1,194,634 | 51.95M |
| 110 | VCEL | Vericel Corporation | 1.71B | -1.38% | 93,827 | 276.26M |
| 111 | INVA | Innoviva, Inc. | 1.70B | -0.09% | 134,053 | 411.33M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.66B | -3.00% | 57,874 | - |
| 113 | NRIX | Nurix Therapeutics, Inc. | 1.66B | 1.39% | 684,700 | 83.98M |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.65B | -0.95% | 3,787,886 | 74.68M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.61B | -2.26% | 452,655 | - |
| 116 | IMCR | Immunocore Holdings plc | 1.61B | -0.80% | 128,333 | 400.02M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.60B | -4.98% | 138,330 | - |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.59B | -0.61% | 148,494 | 868.45M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.58B | 2.40% | 80,067 | 31.89M |
| 120 | OCS | Oculis Holding AG | 1.54B | -0.95% | 94,889 | 1.51M |
| 121 | NBTX | Nanobiotix S.A. | 1.53B | -9.68% | 44,805 | 38.27M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.53B | -2.78% | 757,683 | 67.67M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.53B | -1.36% | 131,988 | - |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.52B | 2.91% | 47,683 | - |
| 125 | NUVB | Nuvation Bio Inc. | 1.48B | -3.15% | 757,945 | 62.90M |
| 126 | VRDN | Viridian Therapeutics, Inc. | 1.46B | 2.88% | 2,670,599 | 70.85M |
| 127 | ARDX | Ardelyx, Inc. | 1.43B | -2.18% | 746,589 | 407.32M |
| 128 | MBX | MBX Biosciences, Inc. | 1.41B | -4.92% | 942,222 | - |
| 129 | PGEN | Precigen, Inc. | 1.41B | -4.89% | 1,244,626 | 9.68M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.41B | -2.65% | 624,398 | 68.56M |
| 131 | SVRA | Savara Inc. | 1.41B | -0.71% | 466,277 | - |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.40B | 2.64% | 189,499 | - |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.39B | -3.45% | 196,198 | 2.50M |
| 134 | BHVN | Biohaven Ltd. | 1.36B | -1.09% | 407,255 | - |
| 135 | IOVA | Iovance Biotherapeutics, Inc. | 1.35B | -0.61% | 3,307,663 | 263.50M |
| 136 | ATAI | AtaiBeckley Inc. | 1.34B | -4.42% | 1,183,512 | 4.09M |
| 137 | IMTX | Immatics N.V. | 1.34B | -3.01% | 119,735 | 56.67M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | -2.54% | 124,887 | 123.67M |
| 139 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -1.32% | 233,380 | - |
| 140 | ZBIO | Zenas BioPharma, Inc. | 1.30B | -1.75% | 119,168 | 10.00M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.29B | -3.24% | 692,593 | 42.73M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -3.66% | 433,880 | 9.77M |
| 143 | NVAX | Novavax, Inc. | 1.27B | -2.20% | 781,418 | 1.12B |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.22B | - | 276,945 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | -3.06% | 230,141 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.17B | -0.59% | 67,795 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.16B | -1.21% | 3,206 | 376.13M |
| 148 | GERN | Geron Corporation | 1.13B | 0.57% | 6,237,958 | 183.88M |
| 149 | SEPN | Septerna, Inc. | 1.10B | -1.57% | 40,254 | 45.95M |
| 150 | EYPT | EyePoint, Inc. | 1.08B | -0.92% | 265,147 | 31.37M |
| 151 | AVBP | ArriVent BioPharma, Inc. | 1.07B | -2.60% | 39,352 | - |
| 152 | QURE | uniQure N.V. | 1.06B | -2.13% | 359,592 | 16.10M |
| 153 | IVA | Inventiva S.A. | 1.04B | -6.35% | 130,729 | 9.31M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -0.83% | 413,893 | 291.85M |
| 155 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | -2.18% | 646,937 | 73.62M |
| 156 | MPLT | MapLight Therapeutics, Inc. | 986.58M | -0.88% | 53,532 | - |
| 157 | ABCL | AbCellera Biologics Inc. | 983.76M | -4.28% | 1,693,866 | 75.13M |
| 158 | CMPX | Compass Therapeutics, Inc. | 943.66M | -4.55% | 640,348 | 850.00K |
| 159 | ANNX | Annexon, Inc. | 919.52M | -1.21% | 641,133 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 918.69M | 1.53% | 160,719 | 6.50M |
| 161 | CTMX | CytomX Therapeutics, Inc. | 910.11M | -4.32% | 1,294,396 | 76.20M |
| 162 | GHRS | GH Research PLC | 899.43M | -4.23% | 38,876 | - |
| 163 | EVMN | Evommune, Inc. | 898.66M | 1.51% | 146,494 | 13.00M |
| 164 | JANX | Janux Therapeutics, Inc. | 893.01M | -1.74% | 202,763 | 10.00M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 889.17M | -0.56% | 369,535 | - |
| 166 | XNCR | Xencor, Inc. | 883.73M | -3.14% | 134,601 | 125.58M |
| 167 | INBX | Inhibrx Biosciences, Inc. | 882.70M | -5.16% | 65,164 | 1.30M |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 880.66M | -2.48% | 155,961 | - |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 879.39M | -0.80% | 346,328 | 175.11M |
| 170 | URGN | UroGen Pharma Ltd. | 867.52M | -4.25% | 189,435 | 109.79M |
| 171 | FTRE | Fortrea Holdings Inc. | 861.14M | 2.22% | 292,082 | 2.72B |
| 172 | ABUS | Arbutus Biopharma Corporation | 856.19M | -1.79% | 280,931 | 14.08M |
| 173 | TBPH | Theravance Biopharma, Inc. | 843.97M | 1.80% | 138,537 | 107.46M |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 811.26M | -2.62% | 320,265 | 84.28M |
| 175 | SANA | Sana Biotechnology, Inc. | 808.61M | -5.90% | 845,262 | - |
| 176 | VOR | Vor Biopharma Inc. | 801.95M | -9.04% | 853,932 | - |
| 177 | SLS | SELLAS Life Sciences Group, Inc. | 796.45M | -2.10% | 1,296,237 | - |
| 178 | JBIO | Jade Biosciences, Inc. | 772.79M | -3.09% | 123,428 | - |
| 179 | MNKD | MannKind Corporation | 770.25M | -2.34% | 1,001,623 | 348.97M |
| 180 | OMER | Omeros Corporation | 751.64M | -4.09% | 488,363 | - |
| 181 | MGTX | MeiraGTx Holdings plc | 748.49M | -3.47% | 199,673 | 81.39M |
| 182 | KURA | Kura Oncology, Inc. | 741.97M | -1.06% | 219,958 | 67.48M |
| 183 | DSGN | Design Therapeutics, Inc. | 741.92M | -3.99% | 181,466 | - |
| 184 | TENX | Tenax Therapeutics, Inc. | 737.40M | -1.48% | 91,653 | - |
| 185 | SLDB | Solid Biosciences Inc. | 736.95M | -3.23% | 287,082 | - |
| 186 | MRVI | Maravai LifeSciences Holdings, Inc. | 735.21M | -3.05% | 751,127 | 185.74M |
| 187 | DRUG | Bright Minds Biosciences Inc. | 732.20M | -0.59% | 28,152 | - |
| 188 | ARVN | Arvinas, Inc. | 713.17M | -0.62% | 191,198 | 262.60M |
| 189 | RLMD | Relmada Therapeutics, Inc. | 694.36M | -4.06% | 245,037 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 690.59M | -8.79% | 25,303 | - |
| 191 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | - | 600,695 | 49.80M |
| 192 | ANRO | Alto Neuroscience, Inc. | 672.77M | -6.52% | 71,118 | - |
| 193 | REPL | Replimune Group, Inc. | 659.76M | -6.44% | 1,091,679 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 651.47M | -8.64% | 86,940 | - |
| 195 | LBRX | LB Pharmaceuticals Inc | 640.57M | -6.01% | 114,038 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 639.20M | -1.69% | 23,617 | 116.59M |
| 197 | CBIO | Crescent Biopharma, Inc. | 618.77M | -3.87% | 57,010 | 10.84M |
| 198 | ALLO | Allogene Therapeutics, Inc. | 616.76M | -2.69% | 1,458,124 | 22.00K |
| 199 | DRTS | Alpha Tau Medical Ltd. | 607.71M | 1.10% | 96,609 | - |
| 200 | MDXG | MiMedx Group, Inc. | 582.38M | 1.03% | 179,902 | 418.63M |
| 201 | OCGN | Ocugen, Inc. | 571.05M | -4.52% | 2,182,289 | 4.41M |
| 202 | PRME | Prime Medicine, Inc. | 569.31M | -3.74% | 657,505 | 4.63M |
| 203 | CRMD | CorMedix Inc. | 557.31M | -0.42% | 218,284 | 311.71M |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 554.82M | -2.98% | 185,422 | 106.47M |
| 205 | PROK | ProKidney Corp. | 554.02M | 1.38% | 323,421 | 893.00K |
| 206 | ZURA | Zura Bio Limited | 549.36M | -4.46% | 177,630 | - |
| 207 | VALN | Valneva SE | 543.61M | -1.34% | 45,274 | 205.07M |
| 208 | KYTX | Kyverna Therapeutics, Inc. | 538.66M | -0.78% | 173,084 | - |
| 209 | PRTA | Prothena Corporation plc | 536.71M | -0.70% | 136,296 | 9.68M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 533.63M | -5.20% | 108,858 | - |
| 211 | AGMB | AgomAb Therapeutics NV | 521.00M | -8.63% | 73,736 | - |
| 212 | UPB | Upstream Bio, Inc. | 514.81M | -2.67% | 85,696 | 2.85M |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 513.59M | -2.76% | 389,775 | 7.83M |
| 214 | LRMR | Larimar Therapeutics, Inc. | 509.03M | -2.97% | 293,108 | - |
| 215 | FULC | Fulcrum Therapeutics, Inc. | 505.83M | -3.00% | 344,283 | 80.00M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 505.41M | -0.40% | 314,951 | 85.21M |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 503.21M | -0.44% | 76,953 | 294.28M |
| 218 | FBRX | Forte Biosciences, Inc. | 500.55M | 0.87% | 64,412 | - |
| 219 | LYEL | Lyell Immunopharma, Inc. | 500.16M | -1.15% | 35,187 | 36.00K |
| 220 | ENGN | enGene Holdings Inc. | 495.05M | 2.07% | 116,083 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 489.10M | -2.53% | 49,474 | - |
| 222 | EIKN | Eikon Therapeutics, Inc. | 487.25M | -4.66% | 124,903 | - |
| 223 | TRDA | Entrada Therapeutics, Inc. | 487.08M | -2.52% | 29,702 | 25.42M |
| 224 | YDES | YD Bio Limited | 480.99M | -3.97% | 4,627 | 510.36K |
| 225 | STTK | Shattuck Labs, Inc. | 469.82M | -3.17% | 97,668 | 1.00M |
| 226 | AVIR | Atea Pharmaceuticals, Inc. | 466.48M | -0.26% | 79,612 | - |
| 227 | VSTM | Verastem, Inc. | 462.01M | -4.01% | 345,999 | 30.91M |
| 228 | ADCT | ADC Therapeutics SA | 458.63M | -1.63% | 244,978 | 81.36M |
| 229 | ASMB | Assembly Biosciences, Inc. | 453.04M | -2.26% | 26,863 | 72.30M |
| 230 | VTVT | vTv Therapeutics Inc. | 451.46M | -7.99% | 54,228 | 17.00K |
| 231 | RGNX | REGENXBIO Inc. | 441.33M | -2.84% | 128,737 | 170.44M |
| 232 | IMMX | Immix Biopharma, Inc. | 440.67M | -3.14% | 261,734 | - |
| 233 | ALT | Altimmune, Inc. | 438.45M | 1.20% | 779,074 | 41.00K |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.01M | -4.51% | 63,987 | - |
| 235 | LXEO | Lexeo Therapeutics, Inc. | 434.89M | 1.73% | 296,562 | - |
| 236 | ABSI | Absci Corporation | 433.05M | -4.39% | 1,571,319 | 2.80M |
| 237 | ARMP | Armata Pharmaceuticals, Inc. | 422.01M | 9.19% | 55,546 | 4.90M |
| 238 | AURA | Aura Biosciences, Inc. | 419.54M | -2.10% | 161,823 | - |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 418.78M | 1.65% | 436,606 | 216.11M |
| 240 | STRO | Sutro Biopharma, Inc. | 410.87M | 3.55% | 66,228 | 102.48M |
| 241 | XOMA | XOMA Royalty Corporation | 408.23M | 1.51% | 66,765 | 52.15M |
| 242 | IPSC | Century Therapeutics, Inc. | 406.17M | 3.20% | 978,201 | 109.16M |
| 243 | NAUT | Nautilus Biotechnology, Inc. | 389.82M | -8.06% | 175,502 | - |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 376.12M | -1.95% | 385,924 | 14.56M |
| 245 | NMRA | Neumora Therapeutics, Inc. | 375.00M | -2.83% | 336,060 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 374.93M | -2.49% | 26,181 | 66.98M |
| 247 | DNA | Ginkgo Bioworks Holdings, Inc. | 370.20M | -7.42% | 277,940 | 170.16M |
| 248 | BNTC | Benitec Biopharma Inc. | 369.95M | -1.73% | 14,002 | - |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 368.05M | -2.02% | 696,470 | - |
| 250 | PRTC | PureTech Health plc | 364.17M | -0.58% | 1,395 | 6.39M |
| 251 | IVVD | Invivyd, Inc. | 361.72M | -1.54% | 884,637 | 53.43M |
| 252 | CADL | Candel Therapeutics, Inc. | 358.54M | -2.49% | 458,942 | - |
| 253 | AUTL | Autolus Therapeutics plc | 357.96M | -3.24% | 468,782 | 75.39M |
| 254 | NAGE | Niagen Bioscience, Inc. | 355.50M | -0.89% | 125,099 | 129.42M |
| 255 | AVTX | Avalo Therapeutics, Inc. | 355.27M | -4.18% | 97,892 | 59.00K |
| 256 | PBYI | Puma Biotechnology, Inc. | 352.07M | 0.44% | 154,835 | 228.37M |
| 257 | NGEN | NervGen Pharma Corp. | 348.00M | -2.05% | 397,627 | - |
| 258 | DMAC | DiaMedica Therapeutics Inc. | 347.00M | -2.72% | 56,233 | - |
| 259 | MNPR | Monopar Therapeutics Inc. | 342.82M | -4.43% | 58,177 | - |
| 260 | IMRX | Immuneering Corporation | 339.43M | -2.78% | 203,454 | - |
| 261 | ANL | Adlai Nortye Ltd. | 339.11M | 2.11% | 229,711 | -1.35M |
| 262 | XFOR | X4 Pharmaceuticals, Inc. | 338.68M | -8.48% | 191,096 | 35.11M |
| 263 | PRLD | Prelude Therapeutics Incorporated | 333.44M | 9.78% | 268,293 | 12.14M |
| 264 | BCYC | Bicycle Therapeutics plc | 332.50M | -2.45% | 182,493 | 72.59M |
| 265 | CABA | Cabaletta Bio, Inc. | 332.30M | -0.83% | 592,813 | - |
| 266 | IRD | Opus Genetics, Inc. | 331.55M | 1.08% | 306,775 | 14.20M |
| 267 | RZLT | Rezolute, Inc. | 324.08M | -4.29% | 236,774 | - |
| 268 | PALI | Palisade Bio, Inc. | 323.96M | 0.26% | 860,122 | - |
| 269 | NGNE | Neurogene Inc. | 314.91M | -1.22% | 19,340 | 925.00K |
| 270 | SRZN | Surrozen, Inc. | 309.45M | -1.68% | 27,096 | 3.48M |
| 271 | CLYM | Climb Bio, Inc. | 303.83M | -5.63% | 172,594 | - |
| 272 | OVID | Ovid Therapeutics Inc. | 298.70M | -1.52% | 2,968,881 | 7.25M |
| 273 | LENZ | LENZ Therapeutics, Inc. | 296.61M | -1.56% | 109,588 | 19.09M |
| 274 | GLSI | Greenwich LifeSciences, Inc. | 293.72M | -3.77% | 65,797 | - |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 290.57M | -4.75% | 234,576 | 1.00 |
| 276 | ADAG | Adagene Inc. | 285.43M | - | 202,978 | 7.67M |
| 277 | ACIU | AC Immune SA | 280.74M | 4.81% | 356,766 | 4.51M |
| 278 | FHTX | Foghorn Therapeutics Inc. | 279.41M | -2.46% | 19,641 | 30.91M |
| 279 | AVXL | Anavex Life Sciences Corp. | 276.16M | 0.68% | 360,395 | - |
| 280 | NBP | NovaBridge Biosciences | 276.12M | -1.03% | 206,218 | - |
| 281 | TARA | Protara Therapeutics, Inc. | 270.42M | -1.38% | 148,049 | - |
| 282 | CCCC | C4 Therapeutics, Inc. | 270.29M | -2.46% | 503,857 | 35.95M |
| 283 | ABEO | Abeona Therapeutics Inc. | 267.56M | -1.47% | 356,301 | 5.82M |
| 284 | ALEC | Alector, Inc. | 264.87M | 2.35% | 161,376 | 21.05M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 261.43M | -3.38% | 60,328 | 114.70K |
| 286 | CLLS | Cellectis S.A. | 260.21M | -1.74% | 6,968 | 79.59M |
| 287 | SLN | Silence Therapeutics plc | 257.90M | -5.86% | 85,778 | 559.00K |
| 288 | EDIT | Editas Medicine, Inc. | 256.91M | -3.49% | 662,058 | 40.52M |
| 289 | HELP | Cybin Inc. | 256.18M | -2.66% | 243,542 | - |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 255.74M | 3.07% | 23,470 | 33.48M |
| 291 | CHRS | Coherus Oncology, Inc. | 240.57M | -3.89% | 409,605 | 42.17M |
| 292 | CAMP | Camp4 Therapeutics Corporation | 237.53M | 1.89% | 38,021 | 3.50M |
| 293 | SLGL | Sol-Gel Technologies Ltd. | 237.17M | -2.41% | 11,441 | 19.39M |
| 294 | PLYX | Polaryx Therapeutics, Inc. | 236.24M | -12.91% | 184,099 | - |
| 295 | ALXO | ALX Oncology Holdings Inc. | 234.92M | -8.93% | 448,266 | - |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 231.93M | -0.73% | 183,360 | 82.03M |
| 297 | CNTX | Context Therapeutics Inc. | 231.54M | -7.01% | 148,483 | - |
| 298 | KROS | Keros Therapeutics, Inc. | 230.89M | -1.35% | 128,400 | 244.06M |
| 299 | VYGR | Voyager Therapeutics, Inc. | 228.27M | -3.53% | 227,843 | 40.37M |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | 226.38M | -3.56% | 563,395 | - |
| 301 | NERV | Minerva Neurosciences, Inc. | 224.16M | -0.96% | 60,638 | - |
| 302 | CGEN | Compugen Ltd. | 218.42M | 5.96% | 267,584 | 72.76M |
| 303 | MDWD | MediWound Ltd. | 217.72M | 2.54% | 69,089 | 16.96M |
| 304 | OABI | OmniAb, Inc. | 213.55M | -4.22% | 149,710 | 18.67M |
| 305 | MGNX | MacroGenics, Inc. | 212.59M | 5.19% | 537,098 | 149.50M |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 211.33M | -4.52% | 44,058 | 44.64M |
| 307 | ENLV | Enlivex Ltd. | 204.58M | -1.35% | 78,493 | - |
| 308 | NVCT | Nuvectis Pharma, Inc. | 203.99M | 0.65% | 24,641 | - |
| 309 | MIST | Milestone Pharmaceuticals Inc. | 203.60M | 9.21% | 1,850,412 | 1.55M |
| 310 | MENS | Jyong Biotech Ltd. | 190.71M | 0.40% | 39,298 | - |
| 311 | KRRO | Korro Bio, Inc. | 188.79M | -5.08% | 71,683 | 6.39M |
| 312 | ELTX | Elicio Therapeutics, Inc. | 184.51M | -6.00% | 64,387 | - |
| 313 | ZNTL | Zentalis Pharmaceuticals, Inc. | 184.41M | -3.35% | 91,208 | 26.87M |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 182.61M | -5.55% | 150,282 | 13.11M |
| 315 | ABOS | Acumen Pharmaceuticals, Inc. | 180.53M | -9.42% | 288,537 | - |
| 316 | CRBU | Caribou Biosciences, Inc. | 179.26M | -4.87% | 401,805 | 11.16M |
| 317 | CDXS | Codexis, Inc. | 178.10M | 3.70% | 878,166 | 70.39M |
| 318 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.53M | -2.96% | 112,776 | - |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 174.44M | -2.04% | 132,142 | 52.74M |
| 320 | PRQR | ProQR Therapeutics N.V. | 173.85M | -8.84% | 323,259 | 19.19M |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 171.95M | -6.62% | 235,622 | - |
| 322 | ACHV | Achieve Life Sciences, Inc. | 168.77M | -1.86% | 193,254 | - |
| 323 | ARTV | Artiva Biotherapeutics, Inc. | 166.10M | -7.82% | 61,548 | 251.00K |
| 324 | WHWK | Whitehawk Therapeutics, Inc. | 161.41M | -2.29% | 96,731 | 7.15M |
| 325 | SGMT | Sagimet Biosciences Inc. | 160.64M | -4.09% | 75,667 | - |
| 326 | RNAC | Cartesian Therapeutics, Inc. | 160.11M | -3.21% | 68,055 | 2.80M |
| 327 | TLSA | Tiziana Life Sciences Ltd | 159.53M | -2.34% | 54,694 | - |
| 328 | NKTX | Nkarta, Inc. | 158.62M | -5.72% | 202,079 | - |
| 329 | UNCY | Unicycive Therapeutics, Inc. | 158.49M | -5.14% | 598,159 | - |
| 330 | IMUX | Immunic, Inc. | 155.25M | 1.71% | 958,293 | - |
| 331 | DTIL | Precision BioSciences, Inc. | 154.17M | -0.58% | 91,551 | 34.26M |
| 332 | KLRS | Kalaris Therapeutics, Inc. | 152.24M | 5.90% | 45,243 | - |
| 333 | CNTB | Connect Biopharma Holdings Limited | 152.04M | -5.94% | 313,639 | 64.00K |
| 334 | SPRO | Spero Therapeutics, Inc. | 151.97M | 0.57% | 345,462 | 66.80M |
| 335 | MOLN | Molecular Partners AG | 151.17M | 1.49% | 3,090 | 856.30K |
| 336 | ACOG | Alpha Cognition Inc. | 149.48M | 10.73% | 63,814 | 10.22M |
| 337 | KPTI | Karyopharm Therapeutics Inc. | 149.01M | 4.59% | 246,737 | 146.07M |
| 338 | AGEN | Agenus Inc. | 148.60M | 2.65% | 583,388 | 114.20M |
| 339 | GALT | Galectin Therapeutics Inc. | 146.14M | -13.28% | 351,226 | - |
| 340 | HRTX | Heron Therapeutics, Inc. | 145.27M | -4.94% | 404,443 | 154.90M |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 140.35M | 0.87% | 25,346 | 2.00M |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 139.92M | -2.30% | 1,703,468 | - |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 138.64M | -3.20% | 286,527 | 70.00M |
| 344 | HUMA | Humacyte, Inc. | 137.27M | -4.88% | 2,104,925 | 2.04M |
| 345 | NTHI | NeOnc Technologies Holdings, Inc. | 133.31M | -2.44% | 39,038 | 39.99K |
| 346 | FATE | Fate Therapeutics, Inc. | 131.96M | -4.62% | 486,700 | 6.65M |
| 347 | EQ | Equillium, Inc. | 128.35M | 1.00% | 173,609 | 4.39M |
| 348 | CBUS | Cibus, Inc. | 126.07M | -13.35% | 250,258 | 3.64M |
| 349 | IPHA | Innate Pharma S.A. | 125.73M | -2.88% | 19,951 | 10.57M |
| 350 | GNLX | Genelux Corporation | 121.14M | - | 78,808 | 8.00K |
| 351 | ANTX | AN2 Therapeutics, Inc. | 117.71M | -2.82% | 25,096 | - |
| 352 | PEPG | PepGen Inc. | 116.11M | -7.69% | 760,185 | - |
| 353 | BMEA | Biomea Fusion, Inc. | 112.79M | 3.31% | 966,940 | - |
| 354 | CRDF | Cardiff Oncology, Inc. | 105.97M | -1.90% | 376,217 | 593.00K |
| 355 | LONA | LeonaBio, Inc. | 105.96M | 2.64% | 24,242 | - |
| 356 | SGMO | Sangamo Therapeutics, Inc. | 104.02M | -9.87% | 3,493,146 | 39.55M |
| 357 | ONCY | Oncolytics Biotech Inc. | 103.98M | -5.75% | 579,585 | - |
| 358 | VRCA | Verrica Pharmaceuticals Inc. | 98.78M | -3.85% | 5,102 | 35.58M |
| 359 | PMN | ProMIS Neurosciences, Inc. | 96.40M | -1.92% | 18,844 | - |
| 360 | TTRX | Turn Therapeutics Inc. | 95.99M | -2.10% | 13,227 | - |
| 361 | SEER | Seer, Inc. | 95.35M | -1.17% | 56,805 | 16.58M |
| 362 | VANI | Vivani Medical, Inc. | 92.27M | -1.80% | 77,095 | - |
| 363 | EXOZ | eXoZymes, Inc. | 92.25M | 8.26% | 8,425 | -700.00 |
| 364 | COYA | Coya Therapeutics, Inc. | 91.72M | -3.46% | 30,006 | 7.95M |
| 365 | ALDX | Aldeyra Therapeutics, Inc. | 90.58M | -2.27% | 598,219 | - |
| 366 | PYXS | Pyxis Oncology, Inc. | 89.22M | -2.07% | 321,704 | 13.86M |
| 367 | AARD | Aardvark Therapeutics, Inc. | 88.09M | -2.23% | 37,907 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 87.84M | 1.16% | 33,826 | - |
| 369 | HURA | TuHURA Biosciences, Inc. | 87.73M | -4.83% | 526,842 | - |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 86.90M | -5.75% | 1,923,247 | 65.34K |
| 371 | QTTB | Q32 Bio Inc. | 86.83M | 5.23% | 96,628 | 53.74M |
| 372 | OKYO | OKYO Pharma Limited | 84.49M | 2.55% | 20,555 | - |
| 373 | NRXS | NeurAxis, Inc. | 84.02M | 1.35% | 57,363 | 3.57M |
| 374 | MCRB | Seres Therapeutics, Inc. | 83.88M | -0.68% | 9,137 | 789.00K |
| 375 | KZIA | Kazia Therapeutics Limited | 83.59M | -0.34% | 4,780 | 1.27M |
| 376 | SPRB | Spruce Biosciences, Inc. | 82.32M | -4.78% | 34,420 | 697.00K |
| 377 | CSBR | Champions Oncology, Inc. | 81.79M | 0.59% | 562 | 57.95M |
| 378 | PTHS | Pelthos Therapeutics Inc. | 81.37M | -0.53% | 14,303 | 16.80M |
| 379 | FLNA | Filana Therapeutics, Inc. | 80.19M | -1.19% | 140,758 | - |
| 380 | PLRX | Pliant Therapeutics, Inc. | 79.56M | -1.91% | 279,274 | - |
| 381 | PYPD | PolyPid Ltd. | 79.20M | -2.12% | 16,366 | - |
| 382 | RANI | Rani Therapeutics Holdings, Inc. | 78.14M | -5.60% | 200,670 | 1.63M |
| 383 | ESLA | Estrella Immunopharma, Inc. | 77.65M | 33.82% | 506,481 | - |
| 384 | ATYR | aTyr Pharma, Inc. | 76.98M | -4.72% | 400,627 | 190.00K |
| 385 | GOSS | Gossamer Bio, Inc. | 75.90M | -6.50% | 3,583,521 | 48.47M |
| 386 | GANX | Gain Therapeutics, Inc. | 74.56M | -5.11% | 313,680 | - |
| 387 | FBIO | Fortress Biotech, Inc. | 73.10M | -9.56% | 987,224 | 63.26M |
| 388 | BYSI | BeyondSpring Inc. | 71.34M | 1.46% | 2,950 | 1.88M |
| 389 | MAIA | MAIA Biotechnology, Inc. | 70.68M | -9.69% | 495,234 | - |
| 390 | IFRX | InflaRx N.V. | 70.64M | 3.58% | 288,936 | 34.44K |
| 391 | NRXP | NRx Pharmaceuticals, Inc. | 70.36M | -5.33% | 377,429 | 1.23M |
| 392 | XBIT | XBiotech Inc. | 70.12M | -0.86% | 15,442 | - |
| 393 | MNOV | MediciNova, Inc. | 69.89M | 0.71% | 6,605 | 409.66K |
| 394 | DWTX | Dogwood Therapeutics, Inc. | 69.81M | 2.45% | 23,895 | - |
| 395 | IBIO | iBio, Inc. | 69.09M | -1.48% | 183,223 | 300.00K |
| 396 | IBO | Impact BioMedical Inc. | 68.65M | -0.52% | 66,051 | 32.00K |
| 397 | CGTX | Cognition Therapeutics, Inc. | 68.59M | -8.37% | 706,096 | - |
| 398 | ACET | Adicet Bio, Inc. | 68.58M | -7.54% | 62,825 | - |
| 399 | GUTS | Fractyl Health, Inc. | 68.30M | -5.80% | 598,091 | 3.00K |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 68.26M | -1.54% | 192,379 | - |
| 401 | CING | Cingulate Inc. | 67.56M | -6.29% | 151,947 | - |
| 402 | COEP | Coeptis Therapeutics Holdings, Inc. | 67.34M | -7.44% | 28,914 | 1.36M |
| 403 | ANVS | Annovis Bio, Inc. | 64.93M | -2.55% | 244,514 | - |
| 404 | ATHE | Alterity Therapeutics Limited | 60.16M | 1.30% | 16,556 | 4.43M |
| 405 | ICCC | ImmuCell Corporation | 59.80M | - | 2,645 | 27.64M |
| 406 | TCRX | TScan Therapeutics, Inc. | 59.18M | - | 486,366 | 10.33M |
| 407 | OKUR | OnKure Therapeutics, Inc. | 58.80M | -1.15% | 30,673 | - |
| 408 | ACRV | Acrivon Therapeutics, Inc. | 57.34M | -5.73% | 226,800 | - |
| 409 | TIL | Instil Bio, Inc. | 56.97M | -0.71% | 20,536 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 56.51M | -0.52% | 12,287 | - |
| 411 | KZR | Kezar Life Sciences, Inc. | 54.55M | - | 18,732 | - |
| 412 | ENTX | Entera Bio Ltd. | 53.15M | -4.19% | 34,504 | 42.00K |
| 413 | IMA | ImageneBio, Inc. | 52.29M | 2.75% | 7,313 | 800.00K |
| 414 | HYFT | MindWalk Holdings Corp. | 52.15M | -7.08% | 70,704 | 20.70M |
| 415 | HOWL | Werewolf Therapeutics, Inc. | 51.51M | 1.92% | 267,822 | 1.14M |
| 416 | RADX | Radiopharm Theranostics Limited | 51.41M | -3.27% | 113,775 | 10.86M |
| 417 | MGX | Metagenomi Therapeutics, Inc. | 50.79M | -0.74% | 50,592 | 25.21M |
| 418 | EDSA | Edesa Biotech, Inc. | 50.65M | -2.06% | 61,987 | - |
| 419 | MREO | Mereo BioPharma Group plc | 50.36M | -0.22% | 493,750 | 500.00K |
| 420 | ACTU | Actuate Therapeutics, Inc. | 49.55M | -0.48% | 107,106 | - |
| 421 | OSTX | OS Therapies Incorporated | 49.18M | -7.87% | 587,728 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 49.15M | 0.47% | 17,627 | 43.77M |
| 423 | ALGS | Aligos Therapeutics, Inc. | 48.39M | -3.34% | 26,720 | 2.19M |
| 424 | PDSB | PDS Biotechnology Corporation | 48.07M | 10.35% | 1,072,372 | - |
| 425 | NTRB | Nutriband Inc. | 47.41M | 4.56% | 3,201 | 2.28M |
| 426 | GRCE | Grace Therapeutics, Inc. | 46.58M | -26.04% | 3,818,553 | - |
| 427 | LSTA | Lisata Therapeutics, Inc. | 45.16M | - | 14,438 | 170.00K |
| 428 | IMMP | Immutep Limited | 44.84M | -5.19% | 208,572 | 5.28M |
| 429 | RLYB | Rallybio Corporation | 43.90M | 2.22% | 65,972 | 858.00K |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | -2.31% | 21,908 | - |
| 431 | RNTX | Rein Therapeutics Inc. | 41.50M | 6.47% | 58,868 | - |
| 432 | RNXT | RenovoRx, Inc. | 41.34M | -1.55% | 90,267 | 1.12M |
| 433 | SNSE | Sensei Biotherapeutics, Inc. | 40.87M | -8.66% | 26,829 | - |
| 434 | CELU | Celularity Inc. | 40.66M | 0.71% | 2,286 | 40.58M |
| 435 | ATOS | Atossa Therapeutics, Inc. | 40.56M | -8.54% | 33,498 | - |
| 436 | LITS | Lite Strategy, Inc. | 40.36M | -2.63% | 39,779 | - |
| 437 | VERU | Veru Inc. | 39.16M | 1.67% | 46,556 | 16.89M |
| 438 | NXTC | NextCure, Inc. | 38.84M | -1.09% | 42,454 | - |
| 439 | ATRA | Atara Biotherapeutics, Inc. | 38.19M | -4.11% | 19,226 | 120.77M |
| 440 | CVM | CEL-SCI Corporation | 36.09M | 3.24% | 67,458 | - |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 35.85M | 5.50% | 79,904 | 90.00K |
| 442 | CRVO | CervoMed Inc. | 35.83M | -2.76% | 11,735 | 4.01M |
| 443 | ABVC | ABVC BioPharma, Inc. | 35.83M | 4.32% | 540,821 | 797.92K |
| 444 | LGVN | Longeveron Inc. | 34.84M | 8.18% | 844,829 | 1.20M |
| 445 | HYPD | Hyperion DeFi, Inc. | 34.74M | -7.58% | 149,194 | 813.46K |
| 446 | PLUR | Pluri Inc. | 34.13M | 4.15% | 1,419 | 1.34M |
| 447 | PTN | Palatin Technologies, Inc. | 33.64M | 7.21% | 19,795 | 8.96M |
| 448 | DYAI | Dyadic International, Inc. | 32.61M | 3.46% | 3,385 | 3.09M |
| 449 | INMB | INmune Bio Inc. | 31.64M | -3.25% | 137,959 | 50.00K |
| 450 | BCTX | BriaCell Therapeutics Corp. | 31.41M | -1.62% | 65,710 | - |
| 451 | APLM | Apollomics, Inc. | 30.49M | 1.43% | 9,395 | 6.93M |
| 452 | EVAX | Evaxion A/S | 29.52M | -4.97% | 10,761 | 7.53M |
| 453 | KYNB | Kyntra Bio, Inc. | 27.72M | -1.86% | 10,014 | 6.44M |
| 454 | SNTI | Senti Biosciences, Inc. | 27.10M | -4.62% | 78,160 | 22.00K |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 27.02M | -3.36% | 10,241 | - |
| 456 | IGC | IGC Pharma, Inc. | 25.87M | 0.71% | 54,239 | 1.11M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 25.57M | -5.08% | 59,292 | - |
| 458 | BOLD | Boundless Bio, Inc. | 25.52M | -3.49% | 20,466 | - |
| 459 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.34M | 0.99% | 8,852 | - |
| 460 | DARE | Daré Bioscience, Inc. | 25.33M | -3.87% | 53,397 | 1.03M |
| 461 | PASG | Passage Bio, Inc. | 25.09M | -10.73% | 48,941 | - |
| 462 | XCUR | Exicure, Inc. | 24.73M | -3.48% | 3,503 | 500.00K |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 24.53M | 5.32% | 38,456 | 14.99M |
| 464 | SER | Serina Therapeutics, Inc. | 24.51M | -7.44% | 69,310 | 130.00K |
| 465 | SKYE | Skye Bioscience, Inc. | 23.77M | -0.30% | 44,418 | - |
| 466 | LEXX | Lexaria Bioscience Corp. | 23.22M | -11.99% | 283,982 | 522.00K |
| 467 | AEON | AEON Biopharma, Inc. | 23.21M | 0.81% | 21,670 | - |
| 468 | NNVC | NanoViricides, Inc. | 23.11M | 5.94% | 105,528 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 22.51M | -4.26% | 36,529 | 3.55M |
| 470 | BRNS | Barinthus Biotherapeutics plc | 22.06M | -5.03% | 1,172 | 14.97M |
| 471 | TPST | Tempest Therapeutics, Inc. | 21.80M | -4.40% | 39,445 | - |
| 472 | PSTV | Plus Therapeutics, Inc. | 21.75M | -4.80% | 1,944,007 | 5.21M |
| 473 | CRIS | Curis, Inc. | 20.71M | -2.81% | 127,184 | 9.44M |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 20.60M | -4.17% | 321,573 | 789.00K |
| 475 | QNTM | Quantum BioPharma Ltd. | 20.31M | 2.23% | 74,642 | - |
| 476 | TVGN | Tevogen Bio Holdings Inc. | 20.18M | -2.61% | 1,389 | - |
| 477 | KTTA | Pasithea Therapeutics Corp. | 20.17M | 1.98% | 49,631 | - |
| 478 | VYNE | VYNE Therapeutics Inc. | 20.17M | 0.27% | 6,237 | 570.00K |
| 479 | OTLK | Outlook Therapeutics, Inc. | 19.86M | -5.38% | 4,721,240 | 205.70K |
| 480 | COCP | Cocrystal Pharma, Inc. | 19.44M | -6.00% | 836,878 | - |
| 481 | ALLR | Allarity Therapeutics, Inc. | 18.43M | -1.27% | 42,366 | 320.00K |
| 482 | CUE | Cue Biopharma, Inc. | 18.23M | 5.48% | 68,507,570 | 27.47M |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 18.21M | -5.35% | 181,106 | 3.94M |
| 484 | JSPR | Jasper Therapeutics, Inc. | 18.18M | -5.13% | 474,751 | - |
| 485 | LTRN | Lantern Pharma Inc. | 18.16M | - | 144,535 | - |
| 486 | PLRZ | Polyrizon Ltd. | 18.09M | -9.35% | 18,349 | - |
| 487 | ICU | SeaStar Medical Holding Corporation | 15.78M | -13.76% | 160,109 | 1.23M |
| 488 | GNTA | Genenta Science S.p.A. | 15.23M | -3.72% | 8,768 | - |
| 489 | CYCN | Cyclerion Therapeutics, Inc. | 15.17M | -13.49% | 743,520 | 2.07M |
| 490 | HIND | Vyome Holdings, Inc. | 14.56M | -3.94% | 9,481 | 319.71K |
| 491 | PHIO | Phio Pharmaceuticals Corp. | 14.46M | -1.19% | 48,900 | - |
| 492 | LPCN | Lipocine Inc. | 14.09M | -0.52% | 1,204,734 | 1.98M |
| 493 | INAB | IN8bio, Inc. | 13.79M | -0.71% | 13,253 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 12.98M | -6.92% | 21,315 | - |
| 495 | TRAW | Traws Pharma, Inc. | 12.97M | -5.60% | 32,241 | 2.85M |
| 496 | BCDA | BioCardia, Inc. | 12.91M | - | 10,107 | 3.00K |
| 497 | GNPX | Genprex, Inc. | 12.84M | -2.08% | 104,698 | - |
| 498 | OSRH | OSR Holdings, Inc. | 12.84M | -3.70% | 363,543 | 2.91M |
| 499 | GTBP | GT Biopharma, Inc. | 12.71M | -9.51% | 253,514 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 12.54M | 1.29% | 26,172 | - |